Third Rock Ventures

United States
cb
Firm Location:United States • Massachusetts • San Francisco, California • Boston, Massachusetts • Oakland, California • Berkeley, California • Cambridge, Massachusetts • Palo Alto, California • South San Francisco, California • Princeton, New Jersey • San Francisco Bay Area
Investor Firms That Co-Invest with Third Rock Ventures
Canaan PartnersAtlas VentureBessemer Venture PartnersGeneral CatalystFlagship VenturesRA CapitalPfizer Venture InvestmentsJohnson & Johnson InnovationSR OneF-Prime Capital PartnersVenrockGV (Google Ventures)Section 32ARCH Venture PartnersAbingworthOrbiMedYsios CapitalFlare Capital PartnersSV Health InvestorsFrazier Healthcare PartnersVivo CapitalPerceptive AdvisorsThe Column GroupSamsara BioCapitalNextech InvestBain Capital Life SciencesCatalio CapitalvenBioSofinnova InvestmentsForbionAstellas Venture ManagementCure Ventures
Third Rock Ventures Team
Photo of Mark Angelino, Venture Partner at Third Rock Ventures
Mark Angelino
Third Rock Ventures·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Cambridge (MA), Investors in Boston (MA)
Investors in BioTech (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Manufacturing (Series B), Investors in Pharmaceuticals (Series B), Investors in Manufacturing (Series A), Investors in Manufacturing (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Manufacturing (Seed), Investors in BioTech (Series A), Investors in Manufacturing (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Manufacturing (Series B), Investors in Pharmaceuticals (Series B), Investors in Boston / New England (Other Lists)
to see your intro paths to Mark
Photo of Hugo Arellano-Santoyo, Senior Associate at Third Rock Ventures
Hugo Arellano-Santoyo
Third Rock Ventures·Senior Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Cambridge (MA), Investors in Boston (MA)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in Boston / New England (Other Lists)
to see your intro paths to Hugo
Photo of Abbie Celniker, Partner at Third Rock Ventures
Abbie Celniker
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA), Investors in Cambridge (MA), Investors in Massachusetts
to see your intro paths to Abbie
Photo of Beryl Cummings, Senior Associate at Third Rock Ventures
Beryl Cummings
Third Rock Ventures·Senior Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA), Investors in San Francisco (CA)
Investors in Medical Devices (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series B), Investors in Boston / New England (Other Lists), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Seed)
to see your intro paths to Beryl
Photo of Andrea van Elsas, Venture Partner at Third Rock Ventures
Andrea van Elsas
Third Rock Ventures·Venture Partner
Sweet spot: $100K
Range: $100K - $5.0M
Investors in Eindhoven (Netherlands), Investors in Netherlands, Investors in SF Bay Area (CA), Investors in Cambridge (MA), Investors in Oakland (CA)
Investors in BioTech (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series B), Investors in Boston / New England (Other Lists)
to see your intro paths to Andrea van
Photo of Neil Exter, Partner at Third Rock Ventures
Neil Exter
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Massachusetts
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A)
to see your intro paths to Neil
Photo of Alan Ezekowitz, Venture Partner at Third Rock Ventures
Alan Ezekowitz
Third Rock Ventures·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA), Investors in Princeton (NJ)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in Boston / New England (Other Lists)
to see your intro paths to Alan
Photo of Jeffrey Finer, Venture Partner at Third Rock Ventures
Jeffrey Finer
Third Rock Ventures·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in SF Bay Area (CA), Investors in South San Francisco (CA)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Series B)
to see your intro paths to Jeffrey
Photo of Kevin Gillis, Partner at Third Rock Ventures
Kevin Gillis
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA), Investors in Massachusetts
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in FinTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in FinTech (Seed), Investors in BioTech (Series A), Investors in FinTech (Series A), Investors in BioTech (Series B), Investors in FinTech (Series B), Investors in Boston / New England (Other Lists), Investors in FinTech (Series A), Investors in FinTech (Seed)
to see your intro paths to Kevin
Photo of Hugo Hilton, Senior Associate at Third Rock Ventures
Hugo Hilton
Third Rock Ventures·Senior Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in South San Francisco (CA), Investors in San Francisco (CA), Investors in SF Bay Area (CA)
Investors in Medical Devices (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Seed)
to see your intro paths to Hugo
Photo of Charles Homcy, Partner at Third Rock Ventures
Charles Homcy
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in SF Bay Area (CA), Investors in San Francisco (CA)
to see your intro paths to Charles
Photo of Reid Huber, Partner at Third Rock Ventures
Reid Huber
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Wilmington (DE), Investors in SF Bay Area (CA), Investors in Cambridge (MA), Investors in Boston (MA)
to see your intro paths to Reid
Photo of Robert Kamen, Venture Partner at Third Rock Ventures
Robert Kamen
Third Rock Ventures·Venture Partner
Sweet spot: $1.5M
Range: $100K - $1.5M
Investors in Shanghai, Investors in Ann Arbor (MI), Investors in Cambridge (MA), Investors in Boston (MA), Investors in Massachusetts
Investors in BioTech (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series B), Investors in Midwest (Other Lists), Investors in Boston / New England (Other Lists)
to see your intro paths to Robert
Photo of David Kaufman, Venture Partner at Third Rock Ventures
David Kaufman
Third Rock Ventures·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in SF Bay Area (CA), Investors in Philadelphia (PA), Investors in Cambridge (MA), Investors in Boston (MA)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in BioTech (Series B), Investors in BioTech (Series B), Investors in Boston / New England (Other Lists)
to see your intro paths to David
Photo of John Keilty, Venture Partner at Third Rock Ventures
John Keilty
Third Rock Ventures·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Cambridge (MA), Investors in Massachusetts
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Boston / New England (Other Lists)
to see your intro paths to John
Photo of Lorence Kim, Venture Partner at Third Rock Ventures
Lorence Kim
Third Rock Ventures·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York City, Investors in Boston (MA), Investors in Cambridge (MA)
Investors in BioTech (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series B), Investors in Boston / New England (Other Lists)
to see your intro paths to Lorence
Photo of Maria Kousi, Senior Associate at Third Rock Ventures
Maria Kousi
Third Rock Ventures·Senior Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Medical Devices (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in Boston / New England (Other Lists), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Seed)
to see your intro paths to Maria
Photo of Christoph Lengauer, Partner at Third Rock Ventures
Christoph Lengauer
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Cambridge (MA), Investors in Boston (MA)
Investors in BioTech (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Boston / New England (Other Lists)
to see your intro paths to Christoph
Photo of Mark Levin, Partner at Third Rock Ventures
Mark Levin
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in Boston / New England (Other Lists)
to see your intro paths to Mark
Photo of Craig Muir, Partner at Third Rock Ventures
Craig Muir
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA), Investors in Massachusetts
Investors in BioTech (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Boston / New England (Other Lists)
to see your intro paths to Craig
Photo of Steve Paul, Venture Partner at Third Rock Ventures
Steve Paul
Third Rock Ventures·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Cambridge (MA), Investors in Boston (MA), Investors in United States
to see your intro paths to Steve
Photo of Cary Pfeffer, Partner at Third Rock Ventures
Cary Pfeffer
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
to see your intro paths to Cary
Photo of Vyas Ramanan, Principal at Third Rock Ventures
Vyas Ramanan
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Medical Devices (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Medical Devices (Seed), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Boston / New England (Other Lists)
to see your intro paths to Vyas
Photo of Richard Ransohoff, Venture Partner at Third Rock Ventures
Richard Ransohoff
Third Rock Ventures·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Cambridge (MA), Investors in Boston (MA)
to see your intro paths to Richard
Photo of Philip Reilly, Venture Partner at Third Rock Ventures
Philip Reilly
Third Rock Ventures·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Cambridge (MA), Investors in Boston (MA)
to see your intro paths to Philip
Photo of Ton Schumacher, Venture Partner at Third Rock Ventures
Ton Schumacher
Third Rock Ventures·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Massachusetts
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A)
to see your intro paths to Ton
Photo of Stephen Sherwin, Venture Partner at Third Rock Ventures
Stephen Sherwin
Third Rock Ventures·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in United States
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A)
to see your intro paths to Stephen
Photo of Robert Tepper, Partner at Third Rock Ventures
Robert Tepper
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
to see your intro paths to Robert
Photo of Jeffrey Tong, Partner at Third Rock Ventures
Jeffrey Tong
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Francisco (CA), Investors in Boston (MA), Investors in Palo Alto (CA)
to see your intro paths to Jeffrey
Photo of Andrew Warren, Senior Associate at Third Rock Ventures
Andrew Warren
Third Rock Ventures·Senior Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA), Investors in Cambridge (MA), Investors in Berkeley (CA)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in BioTech (Series B), Investors in Boston / New England (Other Lists)
to see your intro paths to Andrew
Photo of Barbara Weber, Venture Partner at Third Rock Ventures
Barbara Weber
Third Rock Ventures·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Cambridge (MA), Investors in Boston (MA)
Investors in BioTech (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Boston / New England (Other Lists)
to see your intro paths to Barbara
Photo of George Xu, Senior Associate at Third Rock Ventures
George Xu
Third Rock Ventures·Senior Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Palo Alto (CA), Investors in San Francisco (CA)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Series B)
to see your intro paths to George
WK
Walter Kowtoniuk
Sweet spot: $0
Range: $0 - $0
to see your intro paths to Walter